Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, <i>ERBB2</i>–Negative Metastatic Breast Cancer
Pier Paolo Maria Berton Giachetti(University of Milan), Carmen Criscitiello(University of Milan), Paola Zagami(University of Milan), Claudio Vernieri(IFOM), Sara Gandini(European Institute of Oncology), Eleonora Nicolò(Cornell University), Emma Zattarin(University of Modena and Reggio Emilia), Fabiola Giudici(University of Padua), Chiara Corti(University of Milan), Beatrice Taurelli Salimbeni(European Institute of Oncology), Michelino De Laurentiis(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Andrea Botticelli(Policlinico Umberto I), Carmine De Angelis(Baylor College of Medicine), Dario Trapani(Harvard University), Simone Scagnoli(Sapienza University of Rome), Elisabetta Munzone(Istituti di Ricovero e Cura a Carattere Scientifico), Ambra Carnevale Schianca(University of Milan), Giampaolo Bianchini(Vita-Salute San Raffaele University), Annarita Verrazzo(Scuola Superiore Meridionale), Stefania Morganti(Broad Institute), Caterina Sposetti(Harvard University), Mario Giuliano(Regione Campania), Giulia Viale(Istituti di Ricovero e Cura a Carattere Scientifico), Roberta Scafetta(Università Campus Bio-Medico), Matteo Lambertini(Ospedale Policlinico San Martino), Maria Grazia Razeti(Ospedale Policlinico San Martino), Antonio Marra(Memorial Sloan Kettering Cancer Center), Laura Boldrini(University of Milan), Angela Espósito(European Institute of Oncology), Bianca Malagutti(University of Milan), Roberta Caputo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giuseppe Curigliano(University of Milan)
Cited by 11
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
|Nature Medicine|2019|1.4k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k